Insulet (PODD)
(Delayed Data from NSDQ)
$164.66 USD
-1.59 (-0.96%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $164.33 -0.33 (-0.20%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth D Momentum C VGM
Brokerage Reports
Insulet Corporation [PODD]
Reports for Purchase
Showing records 121 - 140 ( 340 total )
Company: Insulet Corporation
Industry: Medical - Products
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
Medical Devices - 3Q17 Earnings Preview: Anti-climatic due to Seasonally Soft Qtr and Hurricanes
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
Neulasta Onpro Tracker (August): Typical Share Decline After a Strong July
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Neulasta Onpro Tracker (July): Share Up; Quirk in Rx Data Limits Interpretation
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
Medical Devices - Healthcare Conference
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
Solid Quarter and Greater Confidence In PODD''s New European Sales Strategy
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
Neulasta Onpro RX Tracker (June): Adoption Rises for the Month and Quarter
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
2Q17 Earnings Preview: Positive Underlying Dynamics
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
Monthly Neulasta Onpro RX Tracker (May): Share Continues to Steadily Increase
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
Diabetes Technology Insights from the ADA
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
Initial End-User Feedback on 670G System Somewhat Mixed, But A Step In The Right Direction
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
Monthly Neulasta Onpro Prescription Tracker (April): Penetration Inches Higher to 52%
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
Insulet''s 1Q Results Stands out Among its Diabetes Peers; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
Discontinuation of Research Coverage
Provider: Feltl & Company
Company: Insulet Corporation
Industry: Medical - Products
Onpro Kit Exits 1Q17 with 50% Share of Amgen''s Neulasta Franchise and Continues to Grow
Provider: WEDBUSH SECURITIES INC.
Company: Insulet Corporation
Industry: Medical - Products
Monthly Neulasta Onpro Prescription Tracker (March): Share of Onpro Recovers; Now For the First Time Represents Over 50% of Neulasta Franchise
Provider: WEDBUSH SECURITIES INC.